Incidence of oral cancer therapy medication errors at a private university hospital: Rationale for oral cancer therapy specific policies and procedures

2008 ◽  
Vol 26 (15_suppl) ◽  
pp. 6624-6624
Author(s):  
S. D. Stelts ◽  
C. C. Nesheiwat ◽  
J. Ashley ◽  
T. McKibbin ◽  
R. Jennifer ◽  
...  
BMJ Open ◽  
2022 ◽  
Vol 12 (1) ◽  
pp. e055814
Author(s):  
Alessandro Passardi ◽  
Patrizia Serra ◽  
Orazio Caffo ◽  
Carla Masini ◽  
Erika Brugugnoli ◽  
...  

IntroductionONCO-TreC platform consists of a mobile application delivered to patients as electronic diary and a web-based dashboard managed by healthcare professionals. We aim to compare the effectiveness of ONCO-TreC electronic diary with a standard paper diary, in improving adherence to oral cancer therapy in patients with solid and haematological tumours.Methods and analysisThis is an open label, superiority, randomised controlled trial conducted in two Italian oncology units. Patients will be randomised with a 1:1 ratio to electronic or paper diary. For both groups a counsellor will be responsible for drug and diary delivery. The evaluation period will end after six cycles of therapy. The primary aim is to compare the proportion of non-adherent patients in the two arms. Adherence will be measured through pill count; anyone who takes less than 90% of the total prescribed drug dose will be considered non-adherent. Assuming a percentage of non-adherent patients to oral therapy of 40% in arm B, and a 60% reduction in this percentage in arm A, a sample of 124 patients will provide 80% power to identify an absolute difference greater than 24 percentage points using a bilateral Fisher’s exact test with a significance level of 0.05. Considering a dropout rate of 10%, approximately 136 patients will have to be enrolled. The primary analysis will be performed on the intention-to-treat population. Secondary aims are to describe the reasons for non-adherence, the level of satisfaction of patients and healthcare professionals with the paper and electronic diary, and the impact of non-adherence in terms of healthcare costs.Ethics and disseminationEthical approval was obtained from Romagna Ethics Committee (CEROM), study ID 2108, prot. n. IRST 100.28 of 10/04/2020. Informed consent will be obtained from all study participants. Findings will be disseminated through peer-reviewed journals, conferences and event presentations.Protocol versionVersion 2, 6 April 2021.Trial registration numberNCT04826458.


1979 ◽  
Vol 138 (4) ◽  
pp. 508-511 ◽  
Author(s):  
Zelig H. Lieberman ◽  
D.Lamar Byrd ◽  
Tommy J. Davidson
Keyword(s):  

2017 ◽  
Vol 526 (1-2) ◽  
pp. 225-234 ◽  
Author(s):  
Suyeong Nam ◽  
Jeong-Jun Lee ◽  
Song Yi Lee ◽  
Jae Young Jeong ◽  
Wie-Soo Kang ◽  
...  

2006 ◽  
Vol 60 (2) ◽  
pp. 194 ◽  
Author(s):  
Young Ju Jung ◽  
I-Nae Park ◽  
Sang Bum Hong ◽  
Yeon-Mok Oh ◽  
Chae-Man Lim ◽  
...  

2020 ◽  
Vol 25 (6) ◽  
pp. 1067-1071 ◽  
Author(s):  
Yasumasa Kakei ◽  
Hirokazu Komatsu ◽  
Tsutomu Minamikawa ◽  
Takumi Hasegawa ◽  
Masanori Teshima ◽  
...  

Abstract Background No clear consensus has been reached on the indication of supraomohyoid neck dissection (SOHND) for clinically positive lymph-node metastasis. Patients Consecutive 100 patients with previously untreated oral cancer treated at Kobe University Hospital were included in this study. All patients were clinically staged as anyTN1M0 and underwent radical dissection of the primary site and level I–V neck dissection as the initial treatment. Results None of the 100 patients had pathological lymph-node metastasis (pLN) to level V. pLN to level IV was observed in two patients with tongue cancer in whom clinical lymph-node metastasis was preoperatively observed at level II. Conclusions Level V may be excluded in the neck dissection for patients with N1 oral cancers. Level IV dissection should be considered in the patient with tongue cancer and clinical lymph-node metastasis at level II.


2010 ◽  
Vol 10 (1) ◽  
Author(s):  
Sheng Han ◽  
Yan Chen ◽  
Xu Ge ◽  
Ming Zhang ◽  
Jinwei Wang ◽  
...  

Toukeibu Gan ◽  
2017 ◽  
Vol 43 (3) ◽  
pp. 388-392
Author(s):  
Mioko Matsuo ◽  
Rina Jiromaru

Sign in / Sign up

Export Citation Format

Share Document